Brilliant Violet 421™ Streptavidin

Product Details

Verified Reactivity

Human, Mouse, Rat, All Species

Formulation

Cat. No. 405225: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Cat. No. 405226: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Preparation

Streptavidin was conjugated with Brilliant Violet 421™ under optimal conditions.

Concentration

405225 is bottled at 0.5 mg/ml.
405226 is bottled at 0.1 mg/ml.
(concentration relates to the Streptavidin only component of the conjugate)

Storage & Handling

The solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC, ICFC - Quality tested
ICC, IHC-F, IHC-P

Recommended Usage

Each lot of this Streptavidin-Brilliant Violet 421™ is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the Brilliant Violet 421™ conjugation. For immunofluorescent staining, we recommend using Cat. No. 405226 at dilutions ≤ 0.015 µg in 100 µL staining volume per million cells. For applications requiring high concentration of streptavidin reagent such as tetramer labeling, we recommend using Cat. No. 405225. It is recommended that the reagent be titrated for optimal performance for each application.

* Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.

Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

Excitation Laser

Violet Laser (405 nm)

Application Notes

Streptavidin-Brilliant Violet 421™ is useful as a second step reagent for indirect immunofluorescent staining when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-Brilliant Violet 421™ is 340 kD and Streptavidin alone is 52 kD.

Additional Product Notes

View more applications data using this product in immunofluorescence microscopy and labeling tetramers in flow cytometry in our Scientific Poster Library.

Application References

1. Kim G, et al. 2013. J. Immunol. 190:1510. PubMed.
2. Giltiay NV, Et al. 2013. J. Immunol. 191:2155. PubMed
3. Sugiyama D, et al. 2013. PNAS. 110:17945. PubMed
4. Scally SW, et al. 2013. J. Exp Med. 210:2569. PubMed
5. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
6. Higdon LE, et al. 2014. PNAS. 111:5652. PubMed
7. Friedman RS, et al. 2014. PNAS. 111:9223. PubMed
8. van de Weijer ML, et al. 2014. Nat Commun. 5:3832. PubMed
9. Mise-Omata S, et al. 2014. Int Immunol. PubMed
10. Choo JA, et al. 2014. J Virol. 88:10613. PubMed
11. Xing YL, et al. 2014. J Neurosci. 34:14128. PubMed
12. Luetke-Eversloh M, et al. 2014. PLoS Pathog. 10:1004441. PubMed
13. Poh Cm, et al. 2014. Infect Immun. 82:4854. PubMed
14. Cabrera-Perez J, et al. 2015. J Immunol. 194:1609. PubMed
15. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
16. Krishnaswamy JK, et al. 2015. PNAS. 112:3056. PubMed
17. Rampuria P, et al. 2015. Int Immunol. 27:253. PubMed

See More

Product Citations

1. Angkasekwinai P, et al. 2017. PLoS One. 10.1371/journal.pone.0184684. PubMed
2. van Eeden C, et al. 2018. Cell Rep. 25:3123. PubMed
3. Rad S M AH, et al. 2020. PLoS One. 15:e0232915. PubMed
4. Takizawa F, et al. 2016. J Immunol. 196: 4522 - 4535. PubMed
5. Steines L, et al. 2021. Front Immunol. 12:657894. PubMed
6. García-Alegria E, et al. 2021. STAR Protoc. 2:100367. PubMed
7. Reyes RA, et al. 2021. PLoS One. 16:e0261656. PubMed
8. Combes AJ, et al. 2022. Cell. 185:184. PubMed
9. He T, et al. 2022. Liver Int. 42:1287. PubMed
10. Lee JH, et al. 2022. Cell Rep. 38:110485. PubMed
11. Wolf EW, et al. 2022. Proc Natl Acad Sci U S A. 119:e2201794119. PubMed
12. Tátrai P, et al. 2022. EMBO J. 41:e108739. PubMed
13. Lei X, et al. 2022. J Exp Med. 219: . PubMed
14. Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed
15. Wang Z, et al. 2022. J Exp Med. 219: . PubMed
16. Buckner CM, et al. 2022. Cell. 185:4333. PubMed
17. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
18. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
19. Touizer E, et al. 2023. iScience. 26:105862. PubMed
20. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
21. Bettini E, et al. 2022. STAR Protoc. 3:101840. PubMed
22. Guo Q, et al. 2023. Front Public Health. 10:1067342. PubMed
23. Meyer S, et al. 2023. Cell Rep. 42:111995. PubMed
24. Zhang S, et al. 2023. J Clin Med. 12: . PubMed
25. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
26. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
27. Sun P, et al. 2022. iScience. 25:105202. PubMed
28. Tan GMY, et al. 2022. Cancers (Basel). 14:. PubMed
29. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
30. Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed
31. Nihei Y, et al. 2023. Sci Adv. 9:eadd6734. PubMed
32. Marcial-Juárez E, et al. 2023. iScience. 26:106310. PubMed
33. Liu KY, et al. 2023. Environ Health Perspect. 131:37014. PubMed
34. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
35. Lu T, et al. 2023. J Med Virol. 95:e28730. PubMed
36. Fadzeyeva E, et al. 2023. iScience. 26:106748. PubMed
37. Sigmund EC, et al. 2023. PLoS One. 18:e0285597. PubMed
38. Zhang AQ, et al. 2023. Nat Biomed Eng. . PubMed
39. Li H, et al. 2022. Front Immunol. 13:988004. PubMed
40. Chaugule S, et al. 2021. Int J Mol Sci. 22:. PubMed
41. Hayashi M, et al. 2017. EBioMedicine. 15:127-136. PubMed
42. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
43. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
44. Parra–Sánchez H, et al. 2019. Viruses. 1.153472222. PubMed
45. Miura M, et al. 2019. Wellcome Open Res. 3:105. PubMed
46. Kato T, et al. 2019. Front Immunol. 10:2021. PubMed
47. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
48. Xing Y, et al. 2014. J Neurosci. 34:14128. PubMed
49. Sei J, et al. 2016. PLoS One. 11: 0152192. PubMed
50. Li H, et al. 2016. J Immunol. 196: 4064 - 4074. PubMed
51. Sage P, et al. 2016. Nat Immunol. 17:1436-1446. PubMed
52. Xiong W, et al. 2021. Int J Mol Sci. 22:. PubMed
53. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
54. Poon MML, et al. 2021. Sci Immunol. 6:eabl9105. PubMed
55. Trivedi S, et al. 2015. Vaccine. 33: 7315-7327. PubMed
56. Sugiyama D, et al. 2013. Proc Natl Acad Sci U S A. 110:17945. PubMed
57. Giltiay N, et al. 2013. J Immunol. 191:2155. PubMed
58. Krishack PA, et al. 2019. JCI Insight. 4:6. PubMed
59. Mitra T, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.035. PubMed
60. Petursdottir D, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01699. PubMed
61. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
62. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
63. Wu J, et al. 2020. Sci Adv. 6:eaba3458. PubMed
64. Li T, et al. 2022. Int J Infect Dis. 122:874. PubMed
65. Nakagawa T, et al. 2021. Cell Rep. 37:109875. PubMed
66. Gaudette BT, et al. 2021. J Clin Invest. 131:. PubMed
67. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
68. Im S, et al. 2016. Nature. 537:417-421. PubMed
69. Poh C, et al. 2014. Infect Immun . 82:4854. PubMed
70. Cai D, et al. 2021. Front Mol Biosci. 8:686803. PubMed
71. Zhang R, et al. 2021. MAbs. 13:1904546. PubMed
72. Koay H, et al. 2016. Nat Immunol. 10.1038/ni.3565. PubMed
73. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
74. Neumann B, et al. 2019. Cell Stem Cell. 25:473. PubMed
75. Xu L et al. 2017. Immunity. 47(3):538-551 . PubMed
76. Wilmore JR et al. 2018. Cell host & microbe. 23(3):302-311 . PubMed
77. Taguchi A, et al. 2017. Cell Stem Cell. 21:730. PubMed
78. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
79. Krishnaswamy J, et al. 2015. Proc Natl Acad Sci U S A. 112:3056. PubMed
80. Cameron G, et al. 2015. J Immunol. 195: 4604 - 4614. PubMed
81. Rowan A, et al. 2016. PLoS Pathog. 12:e1006030. PubMed
82. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
83. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
84. Tarke A, et al. 2022. Cell. 185:847. PubMed
85. Bähr A, et al. 2016. PLoS One. 11: 0155676. PubMed
86. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
87. Liu B, et al. 2015. J Immunol. 194:3583. PubMed
88. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
89. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
90. Cavazzoni CB, et al. 2022. Cell Rep. 38:110399. PubMed
91. Roberts E, et al. 2016. PLoS One. 11:e0168488. PubMed
92. Elayeb R, et al. 2016. Haematologica. 101: 209 - 218. PubMed
93. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
94. Weijer M, et al. 2014. Nat Commun. 5:3832. PubMed
95. Delacher M, et al. 2020. Immunity. 52:295. PubMed
96. Xi‐Zhi J Guo et al. 2018. Immunity. 49(3):531-544 . PubMed
97. Parra-Sánchez H, et al. 2018. Mol Immunol. 96:1. PubMed
98. Sanjo H, et al. 2015. PLoS One. 10: 0128761. PubMed
99. Ma X, et al. 2020. Immunity. 53:1315. PubMed
100. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
101. Borroto A, et al. 2022. Front Immunol. 13:799919. PubMed
102. Song R, et al. 2022. Front Immunol. 13:1028246. PubMed
103. Yang E, et al. 2016. J Immunol. 197: 934 - 941. PubMed
104. Salzberger W, et al. 2015. PLoS One. 10: 0145324. PubMed
105. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
106. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
107. Scally S, et al. 2013. J Exp Med. 210:2569. PubMed
108. Blomberg R, et al. 2019. Matrix Biol. 83:60. PubMed
109. Cirelli KM et al. 2019. Cell. 177(5):1153-1171 . PubMed
110. Wen J, et al. 2020. Cell Rep. 31:107566. PubMed
111. Claudepierre M, et al. 2014. J Virol. 88:5242. PubMed
112. Friedman R, et al. 2014. Proc Natl Acad Sci U S A. 111:9223. PubMed
113. Lundell A, et al. 2017. Sci Rep. 7:39904. PubMed
114. Fra-Bido S, et al. 2021. STAR Protocols. 2(3):100499. PubMed
115. Wang Z, et al. 2022. J Exp Med. 219:. PubMed
116. Guelen L, et al. 2022. J Immunother Cancer. 10:. PubMed
117. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
118. Lederer K, et al. 2022. Cell. . PubMed
119. Müller TR, et al. 2021. Cell Rep Med. 2:100374. PubMed
120. Dan JM, et al. 2021. Science. :371. PubMed
121. Mise-Omata S, et al. 2014. Int Immunol. 26:607. PubMed
122. An X, et al. 2017. PLoS One.. 10.1371/journal.pone.0181904. PubMed
123. Yoshida H, et al. 2019. Cell. 176:897. PubMed
124. Luetke-Eversloh M, et al. 2014. PLoS Pathog. 10:1004441. PubMed
125. Lang P 2015. Int Immunol. 27:253. PubMed
126. Younis R, et al. 2016. J Immunol. 196: 1419 - 1429. PubMed
127. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
128. Zhu L, et al. 2016. J Cell Sci. 129: 4238 - 4251. PubMed
129. Fries CN, et al. 2021. Sci Rep. 11:14494. PubMed
130. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
131. Wells DK, et al. 2020. Cell. 183:818. PubMed
132. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
133. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
134. Clement RL, et al. 2019. Nat Immunol. 20:1360. PubMed
135. Kim JM, et al. 2020. Nat Commun. 11:2289. PubMed
136. Silva HM, et al. 2019. J Exp Med. 216:786. PubMed
137. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
138. Mahmoudi S, et al. 2019. Nature. 574:553. PubMed
139. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
140. Choo J, et al. 2014. J Virol. 88:10613. PubMed
141. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
142. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
143. Cho A, et al. 2022. J Exp Med. 219:. PubMed
144. Brunk F, et al. 2021. Eur J Immunol. 51:2651. PubMed
145. Giri T, et al. 2022. Heliyon. 8:e09407. PubMed
146. Higdon L, et al. 2014. Proc Natl Acad Sci U S A. 111:5652. PubMed
147. Kim G, et al. 2013. J Immunol. 190:1510. PubMed
148. Binnewies M, et al. 2019. Cell. 177:556. PubMed

See More

Antigen Details

Gene ID

NA

UniProt

View information about Biotin on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Material Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

What is the F/P ratio range of our BV421™ format antibody reagents?

It is lot-specific. On average it ranges between 2-4.

Certificate of Analysis